Therapeutic Goods Act 1989
Approval under section 42DF for use of a restricted representation by Luxottica Retail Australia Pty Ltd
I, Jane Cook, Office Head, Office of Product Review, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing, on receipt of an application by Luxottica Retail Australia Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989 (the Act) the restricted representations described in paragraph (a) below for use in advertisements directed to consumers, for the product identified in paragraph (b):
- "Serious eye diseases", "glaucoma", "macular degeneration" and "retinal changes that may be associated with diabetes" in the context of the statement "Digital Retinal Photography is a powerful tool that helps optometrists detect serious eye diseases including glaucoma, macular degeneration and retinal changes that may be associated with diabetes".
- 'Camera, fundus' (ARTG Number 152527).
Dated this 15th day of January 2013.
Jane Cook
Delegate of the Secretary to the Department of Health and Ageing; and
Office Head
Office of Product Review